1. CowanA. Update of the general pharmacology of buprenorphine. In: LewisJ, CowanA, eds. Buprenorphine: Combating Drug Abuse with a Unique Opioid . New York: Wiley; 1995:31–47.
2. LiuJG, GongZH, QinBY. Effects of opioid receptor agonists on cAMP second messenger system. Zhongguo Yao Li Xue Bao . 1999;20:452–456.[INFOTRIEVE][CSA]
3. JohnsonRE, JonesHE, FischerG. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend . 2003;79:S87–S101.[CSA][CROSSREF]
4. DunlopA, PanjariM, O'SullivanH, . Clinical Guidelines for the Use of Buprenorphine During Pregnancy . Fitzroy: Turning Point Alcohol and Drug Centre, Fitzroy, Australia; 2003.
5. GundersonEW, StimmelB. Treatment of pain in drug addicted persons. In: GalanterM, KleberHD, eds. Textbook of Substance Abuse Treatment. Third edition . Washington, DC: American Psychiatric Pub Inc.; 2004:563–574.